Product Images Orilissa
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 14 images provide visual information about the product associated with Orilissa NDC 0074-0038 by Abbvie Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
orilissa elagolix tablets for oral use 01
orilissa elagolix tablets for oral use 02
This appears to be a table showing the number of subjects and dosage information for a medication called "ORILISSA". The dosages listed are 150mg once daily and 200mg twice daily. The table also includes the number of subjects for each dosage, as well as the number of subjects on and off treatment at different time points (month 0, month 6, and month 12). Without additional context or information, it is unclear what condition this medication is intended to treat.*
orilissa elagolix tablets for oral use 03
orilissa elagolix tablets for oral use 04
This is a not-available text.*
orilissa elagolix tablets for oral use 05
orilissa elagolix tablets for oral use 06
orilissa elagolix tablets for oral use 07
orilissa elagolix tablets for oral use 08
orilissa elagolix tablets for oral use 09
Orilissa is a medication available in tablet form and is represented by the trademark symbol. The remaining text is not available for evaluation as it consists of symbols and non-English characters.*
orilissa elagolix tablets for oral use 0a
orilissa elagolix tablets for oral use 0b
orilissa elagolix tablets for oral use 0c
orilissa elagolix tablets for oral use 0d
orilissa elagolix tablets for oral use 0e
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.